Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 10Terminated 6Withdrawn 2Unknown 2Active not recruiting 2Suspended 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Prostatic Neoplasms 32Brain Neoplasms 21Carcinoma, Non-Small-Cell Lung 19Neoplasm Metastasis 17Lung Neoplasms 15Carcinoma, Hepatocellular 13Breast Neoplasms 10Pancreatic Neoplasms 9Melanoma 9Carcinoma, Renal Cell 9Neoplasms 7Colorectal Neoplasms 7Spinal Cord Neoplasms 3Small Cell Lung Carcinoma 3Prostate Cancer Metastatic 3Nasopharyngeal Carcinoma 3Kidney Neoplasms 3Adenocarcinoma 3Urinary Bladder Neoplasms 2Unresectable Locally Recurrent Rectal Cancer 2Triple Negative Breast Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Radiation Injuries 2Osteosarcoma 2Oligometastatic Prostate Cancer 2Neuroma, Acoustic 2Neoplasms by Site 2Klatskin Tumor 2Head and Neck Neoplasms 2

Interventions

Temozolomide 45Radiotherapy 17Magnetic Resonance Spectroscopy 17Specimen Handling 14pembrolizumab 12Bevacizumab 12Lomustine 9Radiation 8fludarabine 7Cyclophosphamide 7atezolizumab 4Biopsy 4olaparib 3Transurethral Resection of Bladder 3Surgical Procedures, Operative 3Nivolumab 3Leukapheresis 3D2C7-(scdsFv)-PE38KDEL 3Blood Specimen Collection 3Aminolevulinic Acid 3regorafenib 2fluciclovine F-18 2contrast agent BR1 2antisecretory factor 2abemaciclib 2Restraint, Physical 2Re-Irradiation 2Radiation Dose Hypofractionation 2Palliative Care 2Oncolytic Virotherapy 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Glioblastoma × Radiosurgery × Clear all
NCT04977375 2025-09-03

Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma

Cedars-Sinai Medical Center

Phase 1/2 Recruiting
10 enrolled
CNS

Brain Neoplasms, Glioblastoma, Glioma, Spinal Cord Neoplasms, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡